The Breakthrough Drug Whose Full Promise Remains Unrealized The Breakthrough Drug Whose Full Promise Remains Unrealized

With its approval in 2013, sofosbuvir revolutionized treatment for hepatitis C, but the goal of eliminating this disease is still decades away.Medscape Gastroenterology
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology Commentary Source Type: news